332 related articles for article (PubMed ID: 23683735)
1. Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation.
Seiffert M; Diemert P; Koschyk D; Schirmer J; Conradi L; Schnabel R; Blankenberg S; Reichenspurner H; Baldus S; Treede H
JACC Cardiovasc Interv; 2013 Jun; 6(6):590-7. PubMed ID: 23683735
[TBL] [Abstract][Full Text] [Related]
2. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation.
Seiffert M; Bader R; Kappert U; Rastan A; Krapf S; Bleiziffer S; Hofmann S; Arnold M; Kallenbach K; Conradi L; Schlingloff F; Wilbring M; Schäfer U; Diemert P; Treede H
JACC Cardiovasc Interv; 2014 Oct; 7(10):1168-74. PubMed ID: 25129672
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up.
Schlingloff F; Schäfer U; Frerker C; Schmoeckel M; Bader R
Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):388-93. PubMed ID: 24893871
[TBL] [Abstract][Full Text] [Related]
4. Transapical transcatheter aortic valve for severe aortic regurgitation: expanding the limits.
Wendt D; Kahlert P; Pasa S; El-Chilali K; Al-Rashid F; Tsagakis K; Dohle DS; Erbel R; Jakob H; Thielmann M
JACC Cardiovasc Interv; 2014 Oct; 7(10):1159-67. PubMed ID: 25129668
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of pure aortic insufficiency with transapical implantation of the JenaValve.
Bleiziffer S; Mazzitelli D; Nöbauer C; Ried T; Lange R
Thorac Cardiovasc Surg; 2013 Aug; 61(5):428-30. PubMed ID: 23344750
[TBL] [Abstract][Full Text] [Related]
6. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
[TBL] [Abstract][Full Text] [Related]
7. Compassionate use of the self-expandable medtronic CoreValve prosthesis for the treatment of pure aortic regurgitation in a patient at prohibitive risk for surgical valve replacement.
Hildebrandt HA; Erbel R; Kahlert P
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E939-43. PubMed ID: 23197445
[TBL] [Abstract][Full Text] [Related]
8. Transcarotid aortic valve-in-valve implantation for degenerated stentless aortic root conduits with severe regurgitation: a case series.
Huber C; Praz F; O'Sullivan CJ; Langhammer B; Gloekler S; Stortecky S; von Allmen RS; Meier B; Carrel T; Englberger L; Windecker S; Wenaweser P
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):694-700. PubMed ID: 25776924
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter aortic valve implantation for severe, non-calcified aortic regurgitation and narrow aortic root: description from a case report of a new approach to potentially avoid coronary artery obstruction.
Dumonteil N; Marcheix B; Lairez O; Laborde JC
Catheter Cardiovasc Interv; 2013 Aug; 82(2):E124-7. PubMed ID: 22744753
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter aortic valve implantation in patients with severe aortic valve stenosis and large aortic annulus, using the self-expanding 31-mm Medtronic CoreValve prosthesis: first clinical experience.
Nijhoff F; Agostoni P; Amrane H; Latib A; Testa L; Oreglia JA; De Marco F; Samim M; Bedogni F; Maisano F; Bruschi G; Colombo A; Van Boven AJ; Stella PR
J Thorac Cardiovasc Surg; 2014 Aug; 148(2):492-9.e1. PubMed ID: 24263005
[TBL] [Abstract][Full Text] [Related]
11. Transapical implantation of a new second-generation transcatheter heart valve in patients with pure aortic regurgitation: a preliminary report.
Zhu D; Chen Y; Zhang J; Hu J; Guo Y
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):860-2. PubMed ID: 25762716
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
[TBL] [Abstract][Full Text] [Related]
13. A New Transcatheter Aortic Valve Replacement System for Predominant Aortic Regurgitation Implantation of the J-Valve and Early Outcome.
Wei L; Liu H; Zhu L; Yang Y; Zheng J; Guo K; Luo H; Zhao W; Yang X; Maimaiti A; Wang C
JACC Cardiovasc Interv; 2015 Dec; 8(14):1831-41. PubMed ID: 26604056
[TBL] [Abstract][Full Text] [Related]
14. Successful use of a left ventricular apical access and closure device for second-generation transapical aortic valve implantation.
Conradi L; Seiffert M; Shimamura K; Schirmer J; Blankenberg S; Reichenspurner H; Diemert P; Treede H
Thorac Cardiovasc Surg; 2014 Sep; 62(6):498-502. PubMed ID: 24911901
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system.
Binder RK; Schäfer U; Kuck KH; Wood DA; Moss R; Leipsic J; Toggweiler S; Freeman M; Ostry AJ; Frerker C; Willson AB; Webb JG
JACC Cardiovasc Interv; 2013 Mar; 6(3):301-7. PubMed ID: 23517843
[TBL] [Abstract][Full Text] [Related]
16. "Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option".
Pesarini G; Bedogni F; Ribichini F
Catheter Cardiovasc Interv; 2014 Apr; 83(5):836-40. PubMed ID: 24038951
[TBL] [Abstract][Full Text] [Related]
17. Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results.
Bapat V; Attia R; Redwood S; Hancock J; Wilson K; Young C; Thomas M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1372-9; discussion 1379-80. PubMed ID: 23140962
[TBL] [Abstract][Full Text] [Related]
18. Severe intraprosthetic regurgitation and valve embolization after transcatheter aortic valve implantation.
Ben-Dor I; Satler LF; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2013 Feb; 81(2):392-6. PubMed ID: 22566389
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter aortic valve implantation using anatomically oriented, marrow stromal cell-based, stented, tissue-engineered heart valves: technical considerations and implications for translational cell-based heart valve concepts.
Emmert MY; Weber B; Behr L; Sammut S; Frauenfelder T; Wolint P; Scherman J; Bettex D; Grünenfelder J; Falk V; Hoerstrup SP
Eur J Cardiothorac Surg; 2014 Jan; 45(1):61-8. PubMed ID: 23657551
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve.
Binder RK; Rodés-Cabau J; Wood DA; Mok M; Leipsic J; De Larochellière R; Toggweiler S; Dumont E; Freeman M; Willson AB; Webb JG
JACC Cardiovasc Interv; 2013 Mar; 6(3):293-300. PubMed ID: 23517842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
